224 related articles for article (PubMed ID: 27521792)
1. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
[TBL] [Abstract][Full Text] [Related]
2. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
[TBL] [Abstract][Full Text] [Related]
5. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
Sanchez AM; Csibi A; Raibon A; Cornille K; Gay S; Bernardi H; Candau R
J Cell Biochem; 2012 Feb; 113(2):695-710. PubMed ID: 22006269
[TBL] [Abstract][Full Text] [Related]
6. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation.
Xie P; Guo S; Fan Y; Zhang H; Gu D; Li H
J Biol Chem; 2009 Feb; 284(9):5488-96. PubMed ID: 19117950
[TBL] [Abstract][Full Text] [Related]
7. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.
Nakashima K; Yakabe Y
Biosci Biotechnol Biochem; 2007 Jul; 71(7):1650-6. PubMed ID: 17617726
[TBL] [Abstract][Full Text] [Related]
8. Insulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes.
Deng HP; Chai JK; Shen CA; Zhang XB; Ma L; Sun TJ; Hu QG; Chi YF; Dong N
Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26193886
[TBL] [Abstract][Full Text] [Related]
9. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
Skurk C; Izumiya Y; Maatz H; Razeghi P; Shiojima I; Sandri M; Sato K; Zeng L; Schiekofer S; Pimentel D; Lecker S; Taegtmeyer H; Goldberg AL; Walsh K
J Biol Chem; 2005 May; 280(21):20814-23. PubMed ID: 15781459
[TBL] [Abstract][Full Text] [Related]
10. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
11. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
12. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
[TBL] [Abstract][Full Text] [Related]
13. MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.
Baskin KK; Rodriguez MR; Kansara S; Chen W; Carranza S; Frazier OH; Glass DJ; Taegtmeyer H
J Mol Cell Cardiol; 2014 Jul; 72():168-76. PubMed ID: 24650875
[TBL] [Abstract][Full Text] [Related]
14. AMPK inhibits myoblast differentiation through a PGC-1alpha-dependent mechanism.
Williamson DL; Butler DC; Alway SE
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E304-14. PubMed ID: 19491292
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase stabilizes FOXO3 in primary myotubes.
Sanchez AMJ; Candau R; Bernardi H
Biochem Biophys Res Commun; 2018 May; 499(3):493-498. PubMed ID: 29580989
[TBL] [Abstract][Full Text] [Related]
18. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
Stuck BJ; Lenski M; Böhm M; Laufs U
J Biol Chem; 2008 Nov; 283(47):32562-9. PubMed ID: 18790741
[TBL] [Abstract][Full Text] [Related]
19. [Effects of AMPK on the transcriptional activity of FOXO1 and ubiquitin ligase MuRF1 expression in rat cardiomyocytes].
Chen BL; Xiong ZJ; Zhang CX; Ma YD; Meng RS; Chen GQ; Liu C; Dong YG
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov; 30(11):2419-22. PubMed ID: 21097394
[TBL] [Abstract][Full Text] [Related]
20. Loss of thioredoxin 2 alters mitochondrial respiratory function and induces cardiomyocyte hypertrophy.
Hu C; Zhang H; Qiao Z; Wang Y; Zhang P; Yang D
Exp Cell Res; 2018 Nov; 372(1):61-72. PubMed ID: 30236513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]